| |
|
|
|
BioCryst Pharmaceuticals Inc.  
|
|
7.9 0.26 (0.03%) |
03-21 16:00 |
|
Open: |
7.57 |
Pre close: |
7.64 |
Target:
|
10.05 
|
|
High: |
7.93 |
Low: |
7.5551 |
Resistance:
|
8.61
9.26
|
|
Volume: |
313,111 |
Market Cap: |
870M |
Support:
|
7.56
6.29
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.92
|
MACD |
MACD(12,26):
|
-0.22 |
|
MA(20): |
8.25 |
Signal(12,26,9): |
-0.18 |
|
MA(100): |
8.40  |
Stochastic Oscillator |
%K(14,3):
|
10.72 |
|
MA(250): |
7.06 |
%D(3): |
12.30 |
|
Average Volume(K) |
3-Month: |
73292
|
52-Week |
High:
|
9.95 |
|
10-Days: |
69028 |
Low: |
4.53 |
|
RSI |
RSI(14):
|
41.21 |
Change(%): |
51.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.980 |
Return on Equity (ttm) |
31.2 |
Shares Out. (M) |
110.06 |
|
EPS Est. Current Year |
-0.750 |
Return on Assets (ttm) |
-62.3 |
Shares Float (M) |
106.00 |
|
EPS Est. Next Year |
-0.780 |
PEG Ratio |
-0.35 |
% Held by Insiders |
4.10 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-29.8 |
% Held by Institutions |
123.20 |
|
Forward EPS |
-0.900 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
13.220 |
EBITDA (p.s.) |
0.000 |
P/E |
-8.06 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.60 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
4347369984.00 |
|
Operating Margin |
-402.94 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
